Navigation Links
Delcath Announces Completion of Regulatory Notification Process in New Zealand
Date:10/19/2011

bility to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, uncertainties relating to the results of research and development projects and future clinical trials, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.Contact Information:Investor Contact:

Media Contact:Doug Sherk/Gregory Gin

Janine McCargoEVC Group

EVC Group415-568-4887/646-445-4801

646-688-0425
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
2. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
3. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
4. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
5. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
6. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
7. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
8. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
9. Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock
10. Delcath on Preliminary List of Additions to Russell Microcap® Index
11. Delcath to Present at the JMP Securities Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- IGI Laboratories, Inc. (NYSE-MKT: IG), a New Jersey ... today at the Deutsche Bank 40th Annual Health Care Conference. ... and 7 th at The InterContinental Hotel, ... CEO and President and Jenniffer Collins , Chief Financial ... 2015, at 3:30 p.m. ET.   The presentation will be ...
(Date:5/6/2015)... --  Sigma-Aldrich Corporation (NASDAQ: SIAL ) a leading ... $50,000 product donation to the Reproducibility Project: Cancer ... from recent high-impact papers in the field of cancer ... research marketplace Science Exchange , the non-profit ... eLife. The goal of the project is ...
(Date:5/6/2015)... 2015   Symbiomix Therapeutics today announced multiple ... tranche of a $41 million Series A financing and ... testing a single oral dose of SYM-1219 for the ... the U.S. Food and Drug Administration (FDA) at an ... submit the Phase 2 trial as one of two ...
Breaking Medicine Technology:Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 2Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 3Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 4Symbiomix Therapeutics Announces Closing of $41M Financing and Positive Results from a Pivotal Phase 2 Trial of SYM-1219 for the Treatment of Bacterial Vaginosis 5
... (Nasdaq: ENDP ) announced today that it is ... of axomadol. Endo licensed exclusive rights to develop and market ... February 2009. "As a leader in the ... and commercialization of pain therapeutics," said Ivan Gergel, M.D., executive ...
... Endologix, Inc. (Nasdaq: ELGX ), developer and marketer ... Judge Tanya Walton Pratt of the United States District Court ... a Markman ruling in the ongoing patent infringement lawsuit filed ... a Markman ruling, the court determines the meaning of disputed ...
Cached Medicine Technology:Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol 2Endologix Announces Favorable Markman Ruling in Cook Patent Litigation 2
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... Ace Care, has recently announced that they will now ... replacement, for strata complexes in addition to commercial and ... large scale and require a lot of technical knowledge ... “When we do an installation we will take away ...
(Date:5/6/2015)... Va. (PRWEB) May 06, 2015 ... in the state of Virginia to acquire Intuitive ... surgical robot. The system upgrade includes enhanced surgical ... minimally invasive procedures across a wide spectrum of ... options, reduced pain and quicker recovery times. , ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... The Beryl Institute announces the publication of ... (PXJ), an international, open access, peer-reviewed journal focused on ... experience. The second volume of PXJ supports the goal ... the voices engaged and provides the space for listening, ... The Beryl Institute, Volume 2, Issue 1 includes ...
(Date:5/6/2015)... Animals make just as good friends as they do pets. ... An Ohio veterinarian has been observing this for ... advantages of owning a pet. , “When animals and humans ... there are proven health benefits for people-- including physical, mental ... Animal Medical Center of Streetsboro said. Every May, ...
Breaking Medicine News(10 mins):Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3
... Colo., Sept. 11 ,Spectranetics Corporation (Nasdaq: SPNC ... A.G. Edwards Growth Conference, which is being held,September ... John G. Schulte, Spectranetics, president and chief executive ... at 9:30 a.m. Eastern time,(7:30 a.m. Mountain time) ...
... Board of Directors of,Bristol-Myers Squibb Company (NYSE: BMY ... per share on the $.10 par value,Common Stock of ... 1, 2007 to stockholders of record at the close ... declared a quarterly dividend of fifty cents ($0.50),per share ...
... Sept. 11 Washington state nursing,leader Sally Watkins, ... of,Nursing Practice, Education, and Research by the Washington ... professional nurses,association and union. "We are very ... leader,who will be a strong patient and nurse ...
... nuclear power industry is riding the green wave back ... solution to our growing energy needs. But even as ... realistically play, it is bound by a global energy ... by the marketplace. , Veteran New York Times ...
... a third of prostate biopsies resulted in a cancer ... Men whose first biopsy did not find cancer often ... chance of a cancer diagnosis. , While PSA ... cancer screening, a biopsy is what actually determines the ...
... at the University of Oregon and requiring no more ... after a doctors appointment is credited with a 224-percent ... mild developmental delays in a yearlong study. , Researchers ... referrals for special services or additional monitoring would not ...
Cached Medicine News:Health News:Spectranetics to Present at The A.G Edwards Growth Conference on September 18 2Health News:New Director of Nursing Practice Named for Nurses Association 2Health News:Trade-offs reveal no clear favorites in alternative energy market 2Health News:Other highlights in the September 11 JNCI 2Health News:Other highlights in the September 11 JNCI 3Health News:Parental surveys boost diagnosis abilities of pediatricians 2Health News:Parental surveys boost diagnosis abilities of pediatricians 3
... Sterile E*Kits® can be a valuable ... care; when the items necessary for a ... facility protocols and continuum of care are ... are packaged in sequence of use, allowing ...
... trays to dry trays to specialty vaginal ... Cardinal Health offers the widest offering in ... components that are proven to be safe ... of surgical site infections. Cardinal Health Scrub ...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... Panel consists of plasma specimens with reactivity ... antibodies to HTLV I and II. This ... and diagnostic laboratories to evaluate their anti-HTLV ... test systems are included for comparative analysis ...
Medicine Products: